Genetic alterations and aberrant hormonal pathways in thymic epithelial tumors

Le résumé fourni par la source

BACKGROUND: Patients with thymic epithelial tumors (TETs) frequently show coexistence of various paraneoplastic syndromes, which severely affect their survival. Moreover, there is a lack of effective clinical treatment strategies for patients with unresectable metastatic and recurrent TETs. METHODS: To explore the genetic alterations that play a key role in the pathogenesis of TETs, we analyzed the whole-exome sequencing data from 24 patients diagnosed to have TETs at the First Affiliated Hospital of Nanjing Medical University. RESULTS: Mutated genes in TETs were enriched in several hormone-associated pathways such as insulin secretion; Cushing syndrome; parathyroid hormone; and thyroid hormone, as well as multiple classical tumor-associated pathways, including cAMP, Notch, PI3K-Akt, and WNT signaling pathway. Patients with paraneoplastic syndromes (PNS) exhibited more pronounced alterations in hormone-related pathways. RHPN2 is the most frequently mutated gene in TETs. TETs with RHPN2 mutation showed greater upregulation of the hormone-related signaling pathways such as thyroid hormone and parathyroid hormone as well as a trend toward shorter survival of patients. CONCLUSION: We analyzed the possible role of hormones in TETs on several levels, explored potential links between hormones and other genetic mutations, and found that RHPN2 may be a potentially valuable gene.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.